Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

NCT05105971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BAT6026

Sponsor

Bio-Thera Solutions